Gag-p6 Tsg101 Binding Site Duplications in Maternal–Infant HIV Infection
- 1 March 2005
- journal article
- research article
- Published by Mary Ann Liebert Inc in AIDS Research and Human Retroviruses
- Vol. 21 (3) , 191-199
- https://doi.org/10.1089/aid.2005.21.191
Abstract
Prevalence and patterns of HIV p6 duplications in HIV-1 mother-to-baby transmission are examined. Resistance genotyping was performed in a multisite U.S. study of antiretroviral resistance in vertical transmission. Sequence data were used in secondary analyses of HIV genetic variation. Two hundred sixty HIV viral RNA samples from HIV-infected pregnant women and their infants were analyzed with a commercial resistance genotyping kit. Chromatograms were examined for variability in the 3' region of gag. From 103 mother–baby sets, 190 samples gave readable p6 sequence. Of 103 mother–baby sets, 20 (19%) showed duplication of between 3 and 12 codons ending at the PTAPP motif of p6. When maternal p6 duplication was present and the p6 sequence was available from both maternal and infant isolates, all (seven of seven) infants had p6 duplications, but two cases showed discordancies between maternal and infant sequences. The prevalence of p6 duplication varied among geographical sites, ranging from 4 of 43 families (9%, Puerto Rico and New York sites) to 16 of 60 families (27%, Massachusetts, Texas, and Illinois). The presence of p6 duplication was not associated with differences in transmission, viral load, or disease progression in the infants, but showed a trend toward association with lower maternal CD4 count. Substantial p6 variation data are generated by resistance genotyping. PTAP duplication is prevalent in this group of HIV-infected women and infants. The duplication is efficiently transmitted from mother to infant, is present at variable prevalence at different geographic sites, and shows no clear association with vertical transmission risks.Keywords
This publication has 26 references indexed in Scilit:
- Tsg101, an Inactive Homologue of Ubiquitin Ligase E2, Interacts Specifically with Human Immunodeficiency Virus Type 2 Gag Polyprotein and Results in Increased Levels of Ubiquitinated GagJournal of Virology, 2002
- Late Assembly Domain Function Can Exhibit Context Dependence and Involves Ubiquitin Residues Implicated in EndocytosisJournal of Virology, 2002
- The Late Domain of Human Immunodeficiency Virus Type 1 p6 Promotes Virus Release in a Cell Type-Dependent MannerJournal of Virology, 2002
- Biochemical Analyses of the Interactions between Human Immunodeficiency Virus Type 1 Vpr and p6 GagJournal of Virology, 2001
- Resistance to Nucleoside Analog Reverse Transcriptase Inhibitors Mediated by Human Immunodeficiency Virus Type 1 p6 ProteinJournal of Virology, 2001
- Tsg101 and the Vacuolar Protein Sorting Pathway Are Essential for HIV-1 BuddingPublished by Elsevier ,2001
- Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55 GagProceedings of the National Academy of Sciences, 2001
- HIV-1 Vpr-chloramphenicol acetyltransferase fusion proteins: sequence requirement for virion incorporation and analysis of antiviral effectGene Therapy, 1999
- Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release.Proceedings of the National Academy of Sciences, 1991
- Complete nucleotide sequence of the AIDS virus, HTLV-IIINature, 1985